Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine

Vishnu Muthuraj Kumarasamy, Yoon Joo Shin, John White, Daekyu Sun

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: The gain-of-function mutation of the RET proto-oncogene, which encodes a receptor tyrosine kinase, is strongly associated with the development of several medullary thyroid carcinomas (MTCs). Thus, the RET protein has been explored as an excellent target for progressive and advanced MTC. In this study we have demonstrated a therapeutic strategy for MTC by suppressing the transcription of RET proto-oncogene though the stabilization of G-quadruplex structure formed on the promoter region of this gene using a natural product berberine. Methods: Medullary thyroid carcinoma (MTC) TT cell line has been used to evaluate the effects of berberine on RET expression and its downstream signaling pathways. The specificity of berberine was demonstrated by using the papillary thyroid carcinoma TPC1 cell line, which lacks the G-quadruplex forming sequence on the RET promoter region due to chromosomal rearrangement. Results: Berberine suppressed the RET expression by more than 90 % in MTC TT cells at a concentration of 2.5 μg/ml with minimal effect on the TPC1 cells. Canadine, which is a structural analogue of berberine, showed little interaction with RET G-quadruplex and also had no effect on RET expression in MTC TT cells. The down-regulation of RET with berberine further inhibited the cell proliferation through cell cycle arrest and activation of apoptosis in TT cells, which was confirmed by a 2-fold increase in the caspase-3 activity and the down-regulation of cell-cycle regulatory proteins. Conclusion: Our data strongly suggest that the G-quadruplex forming region and the stabilization of this structure play a critical role in mediating the repressive effect of berberine on RET transcription.

Original languageEnglish (US)
Article number599
JournalBMC Cancer
Volume15
Issue number1
DOIs
StatePublished - Aug 26 2015

Fingerprint

Berberine Alkaloids
Berberine
Proto-Oncogenes
G-Quadruplexes
Genetic Promoter Regions
Down-Regulation
Cell Line
Cell Cycle Proteins
Receptor Protein-Tyrosine Kinases
Cell Cycle Checkpoints
Medullary Thyroid cancer
Biological Products
Caspase 3
Cell Proliferation
Apoptosis
Mutation

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Genetics

Cite this

Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine. / Kumarasamy, Vishnu Muthuraj; Shin, Yoon Joo; White, John; Sun, Daekyu.

In: BMC Cancer, Vol. 15, No. 1, 599, 26.08.2015.

Research output: Contribution to journalArticle

Kumarasamy, Vishnu Muthuraj ; Shin, Yoon Joo ; White, John ; Sun, Daekyu. / Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine. In: BMC Cancer. 2015 ; Vol. 15, No. 1.
@article{e67f48c7d11544d7a7b6ff7b391e18a5,
title = "Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine",
abstract = "Background: The gain-of-function mutation of the RET proto-oncogene, which encodes a receptor tyrosine kinase, is strongly associated with the development of several medullary thyroid carcinomas (MTCs). Thus, the RET protein has been explored as an excellent target for progressive and advanced MTC. In this study we have demonstrated a therapeutic strategy for MTC by suppressing the transcription of RET proto-oncogene though the stabilization of G-quadruplex structure formed on the promoter region of this gene using a natural product berberine. Methods: Medullary thyroid carcinoma (MTC) TT cell line has been used to evaluate the effects of berberine on RET expression and its downstream signaling pathways. The specificity of berberine was demonstrated by using the papillary thyroid carcinoma TPC1 cell line, which lacks the G-quadruplex forming sequence on the RET promoter region due to chromosomal rearrangement. Results: Berberine suppressed the RET expression by more than 90 {\%} in MTC TT cells at a concentration of 2.5 μg/ml with minimal effect on the TPC1 cells. Canadine, which is a structural analogue of berberine, showed little interaction with RET G-quadruplex and also had no effect on RET expression in MTC TT cells. The down-regulation of RET with berberine further inhibited the cell proliferation through cell cycle arrest and activation of apoptosis in TT cells, which was confirmed by a 2-fold increase in the caspase-3 activity and the down-regulation of cell-cycle regulatory proteins. Conclusion: Our data strongly suggest that the G-quadruplex forming region and the stabilization of this structure play a critical role in mediating the repressive effect of berberine on RET transcription.",
author = "Kumarasamy, {Vishnu Muthuraj} and Shin, {Yoon Joo} and John White and Daekyu Sun",
year = "2015",
month = "8",
day = "26",
doi = "10.1186/s12885-015-1610-5",
language = "English (US)",
volume = "15",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine

AU - Kumarasamy, Vishnu Muthuraj

AU - Shin, Yoon Joo

AU - White, John

AU - Sun, Daekyu

PY - 2015/8/26

Y1 - 2015/8/26

N2 - Background: The gain-of-function mutation of the RET proto-oncogene, which encodes a receptor tyrosine kinase, is strongly associated with the development of several medullary thyroid carcinomas (MTCs). Thus, the RET protein has been explored as an excellent target for progressive and advanced MTC. In this study we have demonstrated a therapeutic strategy for MTC by suppressing the transcription of RET proto-oncogene though the stabilization of G-quadruplex structure formed on the promoter region of this gene using a natural product berberine. Methods: Medullary thyroid carcinoma (MTC) TT cell line has been used to evaluate the effects of berberine on RET expression and its downstream signaling pathways. The specificity of berberine was demonstrated by using the papillary thyroid carcinoma TPC1 cell line, which lacks the G-quadruplex forming sequence on the RET promoter region due to chromosomal rearrangement. Results: Berberine suppressed the RET expression by more than 90 % in MTC TT cells at a concentration of 2.5 μg/ml with minimal effect on the TPC1 cells. Canadine, which is a structural analogue of berberine, showed little interaction with RET G-quadruplex and also had no effect on RET expression in MTC TT cells. The down-regulation of RET with berberine further inhibited the cell proliferation through cell cycle arrest and activation of apoptosis in TT cells, which was confirmed by a 2-fold increase in the caspase-3 activity and the down-regulation of cell-cycle regulatory proteins. Conclusion: Our data strongly suggest that the G-quadruplex forming region and the stabilization of this structure play a critical role in mediating the repressive effect of berberine on RET transcription.

AB - Background: The gain-of-function mutation of the RET proto-oncogene, which encodes a receptor tyrosine kinase, is strongly associated with the development of several medullary thyroid carcinomas (MTCs). Thus, the RET protein has been explored as an excellent target for progressive and advanced MTC. In this study we have demonstrated a therapeutic strategy for MTC by suppressing the transcription of RET proto-oncogene though the stabilization of G-quadruplex structure formed on the promoter region of this gene using a natural product berberine. Methods: Medullary thyroid carcinoma (MTC) TT cell line has been used to evaluate the effects of berberine on RET expression and its downstream signaling pathways. The specificity of berberine was demonstrated by using the papillary thyroid carcinoma TPC1 cell line, which lacks the G-quadruplex forming sequence on the RET promoter region due to chromosomal rearrangement. Results: Berberine suppressed the RET expression by more than 90 % in MTC TT cells at a concentration of 2.5 μg/ml with minimal effect on the TPC1 cells. Canadine, which is a structural analogue of berberine, showed little interaction with RET G-quadruplex and also had no effect on RET expression in MTC TT cells. The down-regulation of RET with berberine further inhibited the cell proliferation through cell cycle arrest and activation of apoptosis in TT cells, which was confirmed by a 2-fold increase in the caspase-3 activity and the down-regulation of cell-cycle regulatory proteins. Conclusion: Our data strongly suggest that the G-quadruplex forming region and the stabilization of this structure play a critical role in mediating the repressive effect of berberine on RET transcription.

UR - http://www.scopus.com/inward/record.url?scp=84940173372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940173372&partnerID=8YFLogxK

U2 - 10.1186/s12885-015-1610-5

DO - 10.1186/s12885-015-1610-5

M3 - Article

C2 - 26307103

AN - SCOPUS:84940173372

VL - 15

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

IS - 1

M1 - 599

ER -